RNA, U6 small nuclear 1269, pseudogene (RNU6-1269P)

RNU6-1269P, also known as "RNA, U6 small nuclear 1269, pseudogene," is a **pseudogene** of the U6 small nuclear RNA family in humans[1][3]. U6 snRNAs are involved in pre-mRNA splicing as part of the spliceosome, but **pseudogenes** like RNU6-1269P have lost their protein-coding or functional capacity due to mutations or genomic rearrangements[2][3]. These pseudogenes are typically nonfunctional, do not give rise to active RNA or protein products, and largely serve as molecular fossils representing retrotransposition and genome evolution. However, some pseudogenes can exert regulatory effects—such as serving as competing endogenous RNAs, producing small interfering RNAs, or modulating gene expression via epigenetic mechanisms—though such roles have not been reported for RNU6-1269P specifically[4]. There are no known drug interactions, mechanisms of action, or clinical biomarker/therapeutic implications for this pseudogene. Expression of RNU6-1269P has been detected in primordial germ cells and other tissues, but this does not imply functionality[8]. RNU6-1269P is not considered a therapeutic target, nor is it implicated as a receptor, enzyme, transporter, or other protein-coding target in disease or therapy contexts[1][3][8].

Other names

RNU6-1269PU6 small nuclear RNA pseudogene 1269